Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern

by Adam Cuker, Howard A. Liebman
Published 2021-08-01

Second‐line treatments and outcomes for immune thrombocytopenia: A retrospective study with electronic health records

by Lincy S. Lal, Qayyim Said, Katherine Andrade, Adam Cuker
Published 2020-10-01

Microfluidic hemophilia models using blood from healthy donors

by Xinren Yu, Karen A. Panckeri, Lacramioara Ivanciu, Rodney M. Camire, Carmen H. Coxon, Adam Cuker, Scott L. Diamond
Published 2020-01-01

The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli

by Irina N. Chernysh, Chandrasekaran Nagaswami, Sofia Kosolapova, Alina D. Peshkova, Adam Cuker, Douglas B. Cines, Carolyn L. Cambor, Rustem I. Litvinov, John W. Weisel
Published 2020-03-01

In-Hospital Complications and Readmission in Patients with Hemophilia Undergoing Hip or Knee Arthroplasty

by Thita Chiasakul, MD, MSc, Tyler W. Buckner, MD, MSc, Mingyang Li, MS, Rolando Vega, BA, MS, Phyllis A. Gimotty, PhD, Adam Cuker, MD, MS
Published 2020-06-01

Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method

by Adam Cuker, Jenny M. Despotovic, Rachael F. Grace, Caroline Kruse, Michele P. Lambert, Howard A. Liebman, Roger M. Lyons, Keith R. McCrae, Vinod Pullarkat, Jeffrey S. Wasser, David Beenhouwer, Sarah N. Gibbs, Irina Yermilov, Michael S. Broder
Published 2021-01-01

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.

by Yana Pikman, Benjamin H Lee, Thomas Mercher, Elizabeth McDowell, Benjamin L Ebert, Maricel Gozo, Adam Cuker, Gerlinde Wernig, Sandra Moore, Ilene Galinsky, Daniel J DeAngelo, Jennifer J Clark, Stephanie J Lee, Todd R Golub, Martha Wadleigh, D Gary Gilliland, Ross L Levine
Published 2006-07-01